Position in NBIX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$4,887,554
-$374,339 QoQ
Shares Held
37,100
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026KLP KAPITALFORVALTNING AS holds $71,021,294 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
164,074 | $19,395,187 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
22,160 | $13,140,436 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
386,159 | $11,631,109 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
37,100 | $4,887,554 | |
| 5 | VTRS |
Viatris Inc
|
341,600 | $4,615,016 | |
| 6 | ALKS |
Alkermes plc.
|
82,100 | $2,903,056 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
109,900 | $2,629,907 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
31,223 | $2,368,264 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,887,554 | 37,100 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,261,893 | 37,100 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,151,946 | 36,700 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $4,612,823 | 36,700 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,992,660 | 36,100 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,750,200 | 34,800 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||